Integrated Assessment of the Clinical Performance of GalNAc3-Conjugated 2′-O-Methoxyethyl Chimeric Antisense Oligonucleotides: I. Human Volunteer Experience
Nucleic Acid Therapeutics - United States
doi 10.1089/nat.2018.0753
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2019
Authors
Publisher
Mary Ann Liebert Inc